Amanda Littlewood-Evans

ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 8

Top Venues

Science translational medicine

The Journal of experimental medicine

Novartis Institutes for BioMedical Research Basel

University of Bath (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Novartis Institutes for BioMedical Research Basel Oct 01 2007

Switzerland

Lab head :: Autoimmunity, transplantation and inflammation

Education History

University of Bath Jun 01 1998 - May 19 2002

United Kingdom

PHD :: Pharmacology

Publications

Anette C Karle, Matthias B Wrobel, Stephan Koepke, Michael Gutknecht, Sascha Gottlieb, Brigitte Christen, Tina Rubic-Schneider, Ingrid Pruimboom-Brees, Xavier Charles Leber, Meike Scharenberg, Benjamin Maciejewski, Oliver C Turner, Chandrassegar Saravanan, François Huet, Amanda Littlewood-Evans, Andreas Clemens, Cynthia L Grosskreutz, Jeffrey D Kearns, Pawan Mehan, Robert L Schmouder, Vito Sasseville, Dominique Brees
Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse events. Science translational medicine 15 (681) (2023)
Jeffrey D Kearns, Paul Wassmann, Ufuk Olgac, Marie Fichter, Brigitte Christen, Tina Rubic-Schneider, Stephan Koepke, Benjamin Cochin de Billy, David Ledieu, Cedric Andre, Stuart Hawtin, Benoit Fischer, Francesca Moretti, Christian Hug, Alexander Bepperling, Barbara Brannetti, Celia Mendez-Garcia, Amanda Littlewood-Evans, Andreas Clemens, Cynthia L Grosskreutz, Pawan Mehan, Robert L Schmouder, Vito Sasseville, Dominique Brees, Anette C Karle
A root cause analysis to identify the mechanistic drivers of immunogenicity against the anti-VEGF biotherapeutic brolucizumab. Science translational medicine 15 (681) (2023)
Anette C Karle, Matthias B Wrobel, Stephan Koepke, Michael Gutknecht, Sascha Gottlieb, Brigitte Christen, Tina Rubic-Schneider, Ingrid Pruimboom-Brees, Xavier Charles Leber, Meike Scharenberg, Benjamin Maciejewski, Oliver C Turner, Chandrassegar Saravanan, François Huet, Amanda Littlewood-Evans, Andreas Clemens, Cynthia L Grosskreutz, Jeffrey D Kearns, Pawan Mehan, Robert L Schmouder, Vito Sasseville, Dominique Brees
Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse events. Science translational medicine 15 (681) (2023)
Jeffrey D Kearns, Paul Wassmann, Ufuk Olgac, Marie Fichter, Brigitte Christen, Tina Rubic-Schneider, Stephan Koepke, Benjamin Cochin de Billy, David Ledieu, Cedric Andre, Stuart Hawtin, Benoit Fischer, Francesca Moretti, Christian Hug, Alexander Bepperling, Barbara Brannetti, Celia Mendez-Garcia, Amanda Littlewood-Evans, Andreas Clemens, Cynthia L Grosskreutz, Pawan Mehan, Robert L Schmouder, Vito Sasseville, Dominique Brees, Anette C Karle
A root cause analysis to identify the mechanistic drivers of immunogenicity against the anti-VEGF biotherapeutic brolucizumab. Science translational medicine 15 (681) (2023)
Jeffrey D Kearns, Paul Wassmann, Ufuk Olgac, Marie Fichter, Brigitte Christen, Tina Rubic-Schneider, Stephan Koepke, Benjamin Cochin de Billy, David Ledieu, Cedric Andre, Stuart Hawtin, Benoit Fischer, Francesca Moretti, Christian Hug, Alexander Bepperling, Barbara Brannetti, Celia Mendez-Garcia, Amanda Littlewood-Evans, Andreas Clemens, Cynthia L Grosskreutz, Pawan Mehan, Robert L Schmouder, Vito Sasseville, Dominique Brees, Anette C Karle
A root cause analysis to identify the mechanistic drivers of immunogenicity against the anti-VEGF biotherapeutic brolucizumab. Science translational medicine 15 (681) (2023)
Anette C Karle, Matthias B Wrobel, Stephan Koepke, Michael Gutknecht, Sascha Gottlieb, Brigitte Christen, Tina Rubic-Schneider, Ingrid Pruimboom-Brees, Xavier Charles Leber, Meike Scharenberg, Benjamin Maciejewski, Oliver C Turner, Chandrassegar Saravanan, François Huet, Amanda Littlewood-Evans, Andreas Clemens, Cynthia L Grosskreutz, Jeffrey D Kearns, Pawan Mehan, Robert L Schmouder, Vito Sasseville, Dominique Brees
Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse events. Science translational medicine 15 (681) (2023)
Anette C Karle, Matthias B Wrobel, Stephan Koepke, Michael Gutknecht, Sascha Gottlieb, Brigitte Christen, Tina Rubic-Schneider, Ingrid Pruimboom-Brees, Xavier Charles Leber, Meike Scharenberg, Benjamin Maciejewski, Oliver C Turner, Chandrassegar Saravanan, François Huet, Amanda Littlewood-Evans, Andreas Clemens, Cynthia L Grosskreutz, Jeffrey D Kearns, Pawan Mehan, Robert L Schmouder, Vito Sasseville, Dominique Brees
Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse events. Science translational medicine 15 (681) (2023)
Amanda Littlewood-Evans, Sophie Sarret, Verena Apfel, Perrine Loesle, Janet Dawson, Juan Zhang, Alban Muller, Bruno Tigani, Rainer Kneuer, Saijel Patel, Stephanie Valeaux, Nina Gommermann, Tina Rubic-Schneider, Tobias Junt, José M Carballido
GPR91 senses extracellular succinate released from inflammatory macrophages and exacerbates rheumatoid arthritis. The Journal of experimental medicine 213 (9) (2016)

Amanda Littlewood-Evans.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Amanda Littlewood-Evans